CASC2 and endometrial carcinoma: Another lncRNA, Cancer Susceptibility Candidate 2 (CASC2), has been identified as a tumor suppressor in endometrial carcinoma and is known to control cell growth, migration, invasion, and cell death in several types of human cancers.13, 14